All data are based on the daily closing price as of October 6, 2025
b

Bora Pharmaceuticals

6472.TW
22.64 USD
-0.12
-0.53%

Overview

Last close
22.64 usd
Market cap
2.30B usd
52 week high
28.88 usd
52 week low
18.84 usd
Target price
28.58 usd

Valuation

P/E
18.1148
Forward P/E
N/A
Price/Sales
4.0056
Price/Book Value
7.1182
Enterprise Value
3.24B usd
EV/Revenue
4.6333
EV/EBITDA
12.9619

Key financials

Revenue TTM
698.28M usd
Gross Profit TTM
266.82M usd
EBITDA TTM
138.37M usd
Earnings per Share
1.24 usd
Dividend
0.38 usd
Total assets
1.37B usd
Net debt
394.39M usd

About

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.
  • Symbol
    6472.TW
  • Exchange
    TW
  • Isin
    TW0006472004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Taipei
  • Web site
    https://www.bora-corp.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top